Peyton Greenside, Ph.D.CEO at BigHat BiosciencesSpeaker
Agenda Sessions
Co-Chairs' Remarks: Engineering Considerations for Candidate Selection and Developability
, 1:00pmView SessionMachine Learning-driven Design of Next Generation Antibodies with Enhanced Functionality
, 4:15pmView Session
